Blog
The Impact of a Rare Disease Diagnosis on Mental Health
Learn how a rare disease diagnosis and treatment plan can affect a patient’s mental health and what the industry is doing to help support patients’…
All Results
Blog
Blog
The Importance of Increasing Research Participation for Asian Americans
Asian Americans represent five percent of the United States population—a total of 22.9 million individuals. For decades, this population has been…
Blog
Creating Participant-Centric Trials with Remote Participant Monitoring
Improving diversity in the clinical research workforce may improve diversity among clinical trial participants, healthcare access, and equity of care.
Newsletter
Site Engagement Newsletter
In this edition, read insights and updates from PRA’s Site Engagement Team. We explore the role of Clinical Trial Liaisons and how their work…
White Paper
Bridging the Diversity Gap with Decentralized Trials
The current drug development research paradigm is flawed in that it fails to include a diverse and representative patient population. A new approach…
Blog
PRA Health Sciences and Deep Lens, Inc. partner to accelerate patient recruitment for precision cancer trials.
This strategic relationship brings together best-in-class technologies that improve the identification, screening, and matching of cancer patients to…
Blog
Including Children in COVID-19 Trials: Challenges and Opportunities
You may have heard the buzz surrounding a new severe inflammatory condition observed in children that seems to be connected with COVID-19 infection.…
Blog
Understanding the Patient Voice Through Social Listening
What does the patient voice actually sound like? PRA is answering that question by studying how patients, caregivers, and healthcare providers talk…
Blog
Challenges Arise as the Need for Pediatric Research Increases
Many modern providers prescribe off-label treatment to children with “guesstimated” doses, because these drugs have often only been studied in…
Case Study
PRA’s Unique Model Leads to Client Satisfaction
A randomized, multi-center, double-blind study to compare the efficacy and safety of Study Drug A and Study Drug B as monotherapy in newly diagnosed…